(Bloomberg) -- Takeda Pharmaceutical is developing a drug to treat people who have novel coronavirus or are at high risk of contracting it, Dow Jones reports, citing Rajeev Venkayya, president of its vaccine business.
If tests are successful, Takeda will make the drug available in nine to 18 months.
To contact the reporter on this story: Max Zimmerman in Tokyo at mzimmerman90@bloomberg.net
To contact the editor responsible for this story: Niluksi Koswanage at nkoswanage@bloomberg.net